Richard Torstenson

Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study

Yasaman Vali, Jenny Lee, Jérôme Boursier et al. · ˜The œLancet. Gastroenterology & hepatology · 2023 · 171 citations · Full text

Metabolic Syndrome, Biomarker (Medicine), Metabolic Associated Steatohepatitis +14

The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease

Timothy Hardy, Kristy Wonders, Ramy Younes et al. · Contemporary Clinical Trials · 2020 · 128 citations · Full text

Effects of long‐term treatment with oxytocin in chronic constipation; a double blind, placebo‐controlled pilot trial

Bodil Ohlsson, Mikael Truedsson, Mariette Bengtsson et al. · Neurogastroenterology & Motility · 2005 · 89 citations · Full text

Differential effects of levodopa on dopaminergic function in early and advanced Parkinson's disease

Richard Torstenson, Per Hartvig, Bengt Långström et al. · Annals of Neurology · 1997 · 88 citations

Clinical Neuroscience, Social Sciences, Positron Emission Tomography +17

Amphetamine effects on dopamine release and synthesis rate studied in the Rhesus monkey brain by positron emission tomography

Per Hartvig, Richard Torstenson, Joakim Tedroff et al. · Journal of Neural Transmission · 1997 · 69 citations

Positron Emission Tomography, Psychoactive Drug, Neurophysiology +14